Therefore, the combination of CD34 positivity and BRAF V600E mutation we report raises ganglioglioma, pleomorphic xanthoastrocytoma, and dysembryoplastic neuroepithelial tumor as differential diagnostic considerations. Here, BRAF is linked to dysembryoplastic neuroepithelial tumor.